Effects of morning vs evening dosing on the pharmacokinetics and pharmacodynamics of sunitinib. Effect van ochtend- of avondinname van sunitinib op de medicijnspiegels in het bloed

Trial Profile

Effects of morning vs evening dosing on the pharmacokinetics and pharmacodynamics of sunitinib. Effect van ochtend- of avondinname van sunitinib op de medicijnspiegels in het bloed

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Gastrointestinal stromal tumours; Pancreatic cancer; Renal cell carcinoma
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 30 Jul 2012 New source identified and integrated (Netherlands Trial Register; NTR3526).
    • 30 Jul 2012 Additional lead trial centre identified as reported by Netherlands Trial Register.
    • 30 Jul 2012 Planned End Date 1 Jul 2014 added as reported by Netherlands Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top